97 related articles for article (PubMed ID: 7514786)
1. Effect of template secondary structure on the inhibition of HIV-1 reverse transcriptase by a pyridinone non-nucleoside inhibitor.
Olsen DB; Carroll SS; Culberson JC; Shafer JA; Kuo LC
Nucleic Acids Res; 1994 Apr; 22(8):1437-43. PubMed ID: 7514786
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequence.
Carroll SS; Olsen DB; Bennett CD; Gotlib L; Graham DJ; Condra JH; Stern AM; Shafer JA; Kuo LC
J Biol Chem; 1993 Jan; 268(1):276-81. PubMed ID: 7677997
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 2. Analogues of 3-aminopyridin-2(1H)-one.
Saari WS; Wai JS; Fisher TE; Thomas CM; Hoffman JM; Rooney CS; Smith AM; Jones JH; Bamberger DL; Goldman ME
J Med Chem; 1992 Oct; 35(21):3792-802. PubMed ID: 1279173
[TBL] [Abstract][Full Text] [Related]
4. RNA secondary structure switching during DNA synthesis catalyzed by HIV-1 reverse transcriptase.
Suo Z; Johnson KA
Biochemistry; 1997 Dec; 36(48):14778-85. PubMed ID: 9398198
[TBL] [Abstract][Full Text] [Related]
5. Effect of RNA secondary structure on the kinetics of DNA synthesis catalyzed by HIV-1 reverse transcriptase.
Suo Z; Johnson KA
Biochemistry; 1997 Oct; 36(41):12459-67. PubMed ID: 9376350
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 4. 3-[2-(Benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one and analogues.
Hoffman JM; Smith AM; Rooney CS; Fisher TE; Wai JS; Thomas CM; Bamberger DL; Barnes JL; Williams TM; Jones JH
J Med Chem; 1993 Apr; 36(8):953-66. PubMed ID: 7683054
[TBL] [Abstract][Full Text] [Related]
7. A nonnucleoside reverse transcriptase inhibitor active on human immunodeficiency virus type 1 isolates resistant to related inhibitors.
Goldman ME; O'Brien JA; Ruffing TL; Schleif WA; Sardana VV; Byrnes VW; Condra JH; Hoffman JM; Emini EA
Antimicrob Agents Chemother; 1993 May; 37(5):947-9. PubMed ID: 7685996
[TBL] [Abstract][Full Text] [Related]
8. Single unpaired nucleotides facilitate HIV-1 reverse transcriptase displacement synthesis through duplex RNA.
Lanciault C; Champoux JJ
J Biol Chem; 2004 Jul; 279(31):32252-61. PubMed ID: 15169769
[TBL] [Abstract][Full Text] [Related]
9. Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors.
Condra JH; Emini EA; Gotlib L; Graham DJ; Schlabach AJ; Wolfgang JA; Colonno RJ; Sardana VV
Antimicrob Agents Chemother; 1992 Jul; 36(7):1441-6. PubMed ID: 1380789
[TBL] [Abstract][Full Text] [Related]
10. A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group.
Saag MS; Emini EA; Laskin OL; Douglas J; Lapidus WI; Schleif WA; Whitley RJ; Hildebrand C; Byrnes VW; Kappes JC
N Engl J Med; 1993 Oct; 329(15):1065-72. PubMed ID: 7690462
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
Najmudin S; Coté ML; Sun D; Yohannan S; Montano SP; Gu J; Georgiadis MM
J Mol Biol; 2000 Feb; 296(2):613-32. PubMed ID: 10669612
[TBL] [Abstract][Full Text] [Related]
12. Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
Goldman ME; Nunberg JH; O'Brien JA; Quintero JC; Schleif WA; Freund KF; Gaul SL; Saari WS; Wai JS; Hoffman JM
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6863-7. PubMed ID: 1713693
[TBL] [Abstract][Full Text] [Related]
13. Linked lexitropsins and the in vitro inhibition of HIV-1 reverse transcriptase RNA-directed DNA polymerization: a novel induced-fit of 3,5 m-pyridyl bisdistamycin to enzyme-associated template-primer.
Filipowsky ME; Kopka ML; Brazil-Zison M; Lown JW; Dickerson RE
Biochemistry; 1996 Dec; 35(48):15397-410. PubMed ID: 8952492
[TBL] [Abstract][Full Text] [Related]
14. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance.
Tantillo C; Ding J; Jacobo-Molina A; Nanni RG; Boyer PL; Hughes SH; Pauwels R; Andries K; Janssen PA; Arnold E
J Mol Biol; 1994 Oct; 243(3):369-87. PubMed ID: 7525966
[TBL] [Abstract][Full Text] [Related]
15. Effect of RNA secondary structure on RNA cleavage catalyzed by HIV-1 reverse transcriptase.
Suo Z; Johnson KA
Biochemistry; 1997 Oct; 36(41):12468-76. PubMed ID: 9376351
[TBL] [Abstract][Full Text] [Related]
16. Steady state kinetics and inhibition of HIV-1 reverse transcriptase by a non-nucleoside dipyridodiazepinone, BI-RG-587, using a heteropolymeric template.
Kopp EB; Miglietta JJ; Shrutkowski AG; Shih CK; Grob PM; Skoog MT
Nucleic Acids Res; 1991 Jun; 19(11):3035-9. PubMed ID: 1711678
[TBL] [Abstract][Full Text] [Related]
17. Impact of primer-induced conformational dynamics of HIV-1 reverse transcriptase on polymerase translocation and inhibition.
Auger A; Beilhartz GL; Zhu S; Cauchon E; Falgueyret JP; Grobler JA; Ehteshami M; Götte M; Melnyk RA
J Biol Chem; 2011 Aug; 286(34):29575-83. PubMed ID: 21737446
[TBL] [Abstract][Full Text] [Related]
18. DNA secondary structure effects on DNA synthesis catalyzed by HIV-1 reverse transcriptase.
Suo Z; Johnson KA
J Biol Chem; 1998 Oct; 273(42):27259-67. PubMed ID: 9765249
[TBL] [Abstract][Full Text] [Related]
19. Pausing of reverse transcriptase on retroviral RNA templates is influenced by secondary structures both 5' and 3' of the catalytic site.
Harrison GP; Mayo MS; Hunter E; Lever AM
Nucleic Acids Res; 1998 Jul; 26(14):3433-42. PubMed ID: 9649630
[TBL] [Abstract][Full Text] [Related]
20. Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro.
Ji X; Klarmann GJ; Preston BD
Biochemistry; 1996 Jan; 35(1):132-43. PubMed ID: 8555166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
